Please enable JavaScript to continue using this application.

Compare $CGON vs $COGT | Chartloom

Compare

$CGON vs $COGT

CG Oncology Inc · Cogent Biosciences Inc

CGON

CG Oncology Inc

COGT

Cogent Biosciences Inc

Compare $CGON vs $COGT

Comparing CG Oncology Inc and Cogent Biosciences Inc

CGONCG Oncology Inc

COGTCogent Biosciences Inc

CGONCG Oncology Inc

Market cap

$5.63B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

135.78x

Rev growth (TTM)

1030.3%

YTD performance

52.7%

52W performance

56.8%

FCF yield

-3.2%

COGTCogent Biosciences Inc

Market cap

$5.30B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

24.59x

Rev growth (TTM)

—

YTD performance

-10.8%

52W performance

99.0%

FCF yield

-5.8%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CGON

COGT

Detailed metrics comparison

CGON

CG Oncology Inc

COGT

Cogent Biosciences Inc

Market Cap

CGON$5.63B

COGT$5.30B

Enterprise Value

CGON$5.61B

COGT$5.34B

Price

CGON$63.82

COGT$31.00

P/E Ratio

CGONN/A

COGTN/A

P/S Ratio

CGON903.81x

COGT232.42x

EV/Sales

CGON901.14x

COGT234.24x

EV/EBITDA

CGON0.00x

COGT0.00x

P/B Ratio

CGON5.80x

COGT10.11x

P/FCF Ratio

CGONN/A

COGTN/A

EV/FCF

CGON-31.29x

COGT-17.27x

PEG Ratio

CGONN/A

COGTN/A

Forward P/E (NTM)

CGONN/A

COGTN/A

Forward P/S (NTM)

CGON135.78x

COGT24.59x

Revenue (TTM)

CGON$6M

COGT$0

Revenue Growth (YoY)

CGON1030.3%

COGTN/A

Forward Rev Growth

CGON1916.0%

COGT2636.5%

Gross Margin (TTM)

CGON-85.2%

COGT0.0%

Operating Margin (TTM)

CGON0.0%

COGT0.0%

EBITDA Margin (TTM)

CGON-4008.7%

COGT0.0%

Net Margin (TTM)

CGON-3602.7%

COGT0.0%

FCF Margin (TTM)

CGON-2879.6%

COGTN/A

Net Income (TTM)

CGON$-224M

COGT$-332M

FCF (TTM)

CGON$-179M

COGT$-309M

EPS (TTM)

CGON-$2.54

COGT-$1.94

ROE (TTM)

CGON-2520.0%

COGT-7257.0%

ROA (TTM)

CGON-2398.0%

COGT-4865.0%

ROIC (TTM)

CGON-2512.0%

COGT-5402.0%

Cash

CGON$20M

COGT$181M

Debt

CGON$3M

COGT$223M

Net Cash/Debt

CGON$17M

COGT$-42M

Current Ratio (TTM)

CGON22.22x

COGT13.57x

Quick Ratio (TTM)

CGON21.78x

COGT13.36x

Debt/Equity (TTM)

CGON0.00x

COGT0.42x

Debt/Assets (TTM)

CGON0.0%

COGT0.0%

Interest Coverage (TTM)

CGONN/A

COGTN/A

Net Debt/EBITDA (TTM)

CGON0.00x

COGT0.00x

Beta

CGON0.25

COGT0.34

52W Performance

CGON56.8%

COGT99.0%

YTD Performance

CGON52.7%

COGT-10.8%

% from 52W High

CGON-21.2%

COGT-29.1%

% from 52W Low

CGON78.3%

COGT125.0%

Asset Turnover (TTM)

CGON0.01x

COGT0.36x

FCF Yield (TTM)

CGON-3.2%

COGT-5.8%

Earnings Yield (TTM)

CGON-4.0%

COGT-6.3%

Dividend Yield (TTM)

CGONN/A

COGTN/A

Rule of 40

CGON-1,849.3

COGT0.0

EV/GP/RG

CGONN/A

COGTN/A

Ticker research

View CGON research View COGT research

Metric	CGON CG Oncology Inc	COGT Cogent Biosciences Inc
Market & Valuation
Market Cap	$5.63B	$5.30B
Enterprise Value	$5.61B	$5.34B
Price	$63.82	$31.00
P/E Ratio	N/A	N/A
P/S Ratio	903.81x	232.42x
EV/Sales	901.14x	234.24x
EV/EBITDA	0.00x	0.00x
P/B Ratio	5.80x	10.11x
P/FCF Ratio	N/A	N/A
EV/FCF	-31.29x	-17.27x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	135.78x	24.59x
Revenue & Growth
Revenue (TTM)	$6M	$0
Revenue Growth (YoY)	1030.3%	N/A
Forward Rev Growth	1916.0%	2636.5%
Profitability
Gross Margin (TTM)	-85.2%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-4008.7%	0.0%
Net Margin (TTM)	-3602.7%	0.0%
FCF Margin (TTM)	-2879.6%	N/A
Net Income (TTM)	$-224M	$-332M
FCF (TTM)	$-179M	$-309M
EPS (TTM)	-$2.54	-$1.94
ROE (TTM)	-2520.0%	-7257.0%
ROA (TTM)	-2398.0%	-4865.0%
ROIC (TTM)	-2512.0%	-5402.0%
Financial Health
Cash	$20M	$181M
Debt	$3M	$223M
Net Cash/Debt	$17M	$-42M
Current Ratio (TTM)	22.22x	13.57x
Quick Ratio (TTM)	21.78x	13.36x
Debt/Equity (TTM)	0.00x	0.42x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.25	0.34
52W Performance	56.8%	99.0%
YTD Performance	52.7%	-10.8%
% from 52W High	-21.2%	-29.1%
% from 52W Low	78.3%	125.0%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.36x
FCF Yield (TTM)	-3.2%	-5.8%
Earnings Yield (TTM)	-4.0%	-6.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-1,849.3	0.0
EV/GP/RG	N/A	N/A
Ticker research	View CGON research	View COGT research

Valuation

P/S Ratio

COGT

232.42x

CGON

903.81x

EV/FCF

CGON

-31.29x

COGT

-17.27x

Growth & revenue

Revenue Growth TTM

CGON

1030.3%

Forward Revenue Growth

COGT

2636.5%

CGON

1916.0%

Profitability & performance

Gross Margin

COGT

0.0%

CGON

-85.2%

ROE

CGON

-2520.0%

COGT

-7257.0%

FCF Yield %

CGON

-3.2%

COGT

-5.8%

52-Week Performance

COGT

99.0%

CGON

56.8%

Detailed metrics comparison

CGON

CG Oncology Inc

COGT

Cogent Biosciences Inc

Market Cap

CGON$5.63B

COGT$5.30B

Enterprise Value

CGON$5.61B

COGT$5.34B

Price

CGON$63.82

COGT$31.00

P/E Ratio

CGONN/A

COGTN/A

P/S Ratio

CGON903.81x

COGT232.42x

EV/Sales

CGON901.14x

COGT234.24x

EV/EBITDA

CGON0.00x

COGT0.00x

P/B Ratio

CGON5.80x

COGT10.11x

P/FCF Ratio

CGONN/A

COGTN/A

EV/FCF

CGON-31.29x

COGT-17.27x

PEG Ratio

CGONN/A

COGTN/A

Forward P/E (NTM)

CGONN/A

COGTN/A

Forward P/S (NTM)

CGON135.78x

COGT24.59x

Revenue (TTM)

CGON$6M

COGT$0

Revenue Growth (YoY)

CGON1030.3%

COGTN/A

Forward Rev Growth

CGON1916.0%

COGT2636.5%

Gross Margin (TTM)

CGON-85.2%

COGT0.0%

Operating Margin (TTM)

CGON0.0%

COGT0.0%

EBITDA Margin (TTM)

CGON-4008.7%

COGT0.0%

Net Margin (TTM)

CGON-3602.7%

COGT0.0%

FCF Margin (TTM)

CGON-2879.6%

COGTN/A

Net Income (TTM)

CGON$-224M

COGT$-332M

FCF (TTM)

CGON$-179M

COGT$-309M

EPS (TTM)

CGON-$2.54

COGT-$1.94

ROE (TTM)

CGON-2520.0%

COGT-7257.0%

ROA (TTM)

CGON-2398.0%

COGT-4865.0%

ROIC (TTM)

CGON-2512.0%

COGT-5402.0%

Cash

CGON$20M

COGT$181M

Debt

CGON$3M

COGT$223M

Net Cash/Debt

CGON$17M

COGT$-42M

Current Ratio (TTM)

CGON22.22x

COGT13.57x

Quick Ratio (TTM)

CGON21.78x

COGT13.36x

Debt/Equity (TTM)

CGON0.00x

COGT0.42x

Debt/Assets (TTM)

CGON0.0%

COGT0.0%

Interest Coverage (TTM)

CGONN/A

COGTN/A

Net Debt/EBITDA (TTM)

CGON0.00x

COGT0.00x

Beta

CGON0.25

COGT0.34

52W Performance

CGON56.8%

COGT99.0%

YTD Performance

CGON52.7%

COGT-10.8%

% from 52W High

CGON-21.2%

COGT-29.1%

% from 52W Low

CGON78.3%

COGT125.0%

Asset Turnover (TTM)

CGON0.01x

COGT0.36x

FCF Yield (TTM)

CGON-3.2%

COGT-5.8%

Earnings Yield (TTM)

CGON-4.0%

COGT-6.3%

Dividend Yield (TTM)

CGONN/A

COGTN/A

Rule of 40

CGON-1,849.3

COGT0.0

EV/GP/RG

CGONN/A

COGTN/A

Ticker research

View CGON research View COGT research

Metric	CGON CG Oncology Inc	COGT Cogent Biosciences Inc
Market & Valuation
Market Cap	$5.63B	$5.30B
Enterprise Value	$5.61B	$5.34B
Price	$63.82	$31.00
P/E Ratio	N/A	N/A
P/S Ratio	903.81x	232.42x
EV/Sales	901.14x	234.24x
EV/EBITDA	0.00x	0.00x
P/B Ratio	5.80x	10.11x
P/FCF Ratio	N/A	N/A
EV/FCF	-31.29x	-17.27x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	135.78x	24.59x
Revenue & Growth
Revenue (TTM)	$6M	$0
Revenue Growth (YoY)	1030.3%	N/A
Forward Rev Growth	1916.0%	2636.5%
Profitability
Gross Margin (TTM)	-85.2%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-4008.7%	0.0%
Net Margin (TTM)	-3602.7%	0.0%
FCF Margin (TTM)	-2879.6%	N/A
Net Income (TTM)	$-224M	$-332M
FCF (TTM)	$-179M	$-309M
EPS (TTM)	-$2.54	-$1.94
ROE (TTM)	-2520.0%	-7257.0%
ROA (TTM)	-2398.0%	-4865.0%
ROIC (TTM)	-2512.0%	-5402.0%
Financial Health
Cash	$20M	$181M
Debt	$3M	$223M
Net Cash/Debt	$17M	$-42M
Current Ratio (TTM)	22.22x	13.57x
Quick Ratio (TTM)	21.78x	13.36x
Debt/Equity (TTM)	0.00x	0.42x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.25	0.34
52W Performance	56.8%	99.0%
YTD Performance	52.7%	-10.8%
% from 52W High	-21.2%	-29.1%
% from 52W Low	78.3%	125.0%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.36x
FCF Yield (TTM)	-3.2%	-5.8%
Earnings Yield (TTM)	-4.0%	-6.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-1,849.3	0.0
EV/GP/RG	N/A	N/A
Ticker research	View CGON research	View COGT research